• 300 IU of porcine sodium heparin

• isopropanol
• mountain pine oil
• disodium edetat-2 water
• Polyoxyethylene (6)-caprylic acid/capric acid glyceride
• Carbomer 980
• trolamine
• water, purified
• levomenthol
• Polysorbate 80
• Sorbitol 70
• pine needle oil

indication

• The preparation is a medicine used to reduce swelling.
• It is used to support the treatment of acute swelling after blunt injuries (bruises, bruises).
• If you do not feel better or if you feel worse after 10 days, contact your doctor

dosage

• Always use this medicine exactly as described or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
• The recommended dose is
  • The medicine should be applied thinly and evenly to the affected area 2 to 3 times a day.

   

• duration of use
  • The doctor decides on the duration of use. The preparation must not be used for longer than 10 days.

• If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

way

• For application on the skin.
• After use, wash hands thoroughly with soap.

side effects

• Like all medicines, this medicine can cause side effects, although not everybody gets them.
• Rare (may affect up to 1 in 1,000 people):
  • Allergic reactions to heparin when applied to the skin.
• Very rare (may affect up to 1 in 10,000 people):
  • Allergic reactions such as reddening of the skin and itching, which usually disappear quickly after stopping the preparation.
• Not known (cannot be estimated from the available data):
  • The frequency of occurrence of heparin-induced, antibody-mediated type II thrombocytopenia (decrease in platelet count < 100,000/µl or rapid drop in platelet count to < 50% of baseline) with arterial and venous thrombosis or embolism, which can be fatal, is with local application on the skin has not yet been investigated. However, since the absorption of heparin through healthy skin after local application has been described, this risk cannot be ruled out with certainty. Increased attention is therefore indicated. In patients without a history of hypersensitivity to heparin, the drop in blood platelet counts usually begins 6-14 days after the start of treatment.
• countermeasures
  • The drug should be discontinued if allergic skin reactions occur.
  • Please inform your doctor about this. Beyond that, no other special measures are necessary.
• If you get any side effects, talk to your doctor or pharmacist. This also applies to side effects that are not specified.

interactions

• Use together with other medicines
  • Tell your doctor or pharmacist if you are taking/using, have recently taken/used or might take/use any other medicines.
  • Interactions with other drugs are not known for local use.

Contraindications

• The drug must not be used
  • if you are allergic to heparin sodium or any of the other ingredients of this medicine.
  • if you have an acute or a history of an allergic drop in the number of blood platelets (type II thrombocytopenia) caused by heparin.

pregnancy and breast feeding period

• If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
• Previous experience with the use of pregnant and lactating women has not yielded any indications of harmful effects.
• Heparin does not cross the placenta and does not pass into breast milk.

patient notes

• Warnings and Precautions
  • Please talk to your doctor or pharmacist before using this medicine.
  • If new symptoms occur that may indicate thrombosis or pulmonary embolism, such as
    • Swelling and warmth in the affected part of the body
    • reddened and tense skin, possibly turning blue
    • Feeling of tension and pain in the foot, calf and hollow of the knee (relief when lying up)
    • sudden shortness of breath, chest pain and weakness/collapse
  • the presence of heparin-induced thrombocytopenia type II must be ruled out and the blood platelet count (thrombocyte count) must be checked immediately.
  • An increased risk of bleeding cannot be ruled out if drugs that interfere with blood clotting are used at the same time. Bruising may occur more frequently or increase in size.
  • During treatment with this preparation, injections into the muscle should be avoided because of the risk of bruising (hematoma).
  • The medicine contains alcohol and must therefore not be applied to mucous membranes, open wounds and/or weeping eczema and inflamed skin (e.g. sunburn) or come into contact with the eyes, as a burning sensation may occur.

• Ability to drive and use machines
  • The preparation has no or negligible influence on the ability to drive and use machines. The same applies to work without a secure hold.